SHPH: צמיחת מכירות רבעונית Shuttle Pharmaceuticals

סמל מסחרי של shuttlepharma.com (SHPH)

Shuttle Pharmaceuticals is optimizing costs by utilizing contract manufacturing for brain tumor medications. The quarterly revenue growth rate visualizes income dynamics, where 0.00 indicates the level of this metric. Conservative management with an academic background is systematically expanding the clinical trial network. Simultaneously, Shuttle Pharmaceuticals is diversifying risks by developing tissue protection agents for radiation therapy.

Shuttle Pharmaceuticals Inc (SHPH) - שינוי במכירות מרבעון לרבעון מ-28.04.2023 עד 20.11.2026

Shuttle Pharmaceuticals Holdings - פילוחים אנליטיים ומדדי מפתח (SHPH)

- מחיר מניה ומחיר יעד קונצנזוס:
ניתוח בסיסי של החברה:Shuttle Pharmaceuticals - SHPH
מוצר סדרתי של shuttlepharma.com

Conservative capital demands absolute transparency of operating flows to confirm the issuer's financial stability. This indicator measures the percentage change in sales volume between the current and previous quarters, allowing for an assessment of business scaling rates and market expansion. In the case of Shuttle Pharmaceuticals (SHPH), the relative growth in quarterly revenue reflects the commercial realization of radiation sensitizers' potential and the successful implementation of Ropidoxuridine.